Cecilia Larocca

Also affiliated with Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Mass General Brigham

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “IL-32 Supports the Survival of Malignant T Cells in Cutaneous T-cell Lymphoma”.

IL-32 Supports the Survival of Malignant T Cells in Cutaneous T-cell Lymphoma

Journal of Investigative Dermatology(2022)10.1016/j.jid.2022.01.009

N/A

0DataRank · unranked

7 citations

Neal P. Smith, S. Essien, Jessica E. Teague, Pablo Vieyra-Garcia, Ahmed Gehad +11 more

Phototherapy Restores Deficient Type I IFN Production and Enhances Antitumor Responses in Mycosis Fungoides

Journal of Investigative Dermatology(2023)10.1016/j.jid.2023.06.212

N/A

0DataRank · unranked

7 citations

Pablo Vieyra-Garcia, Theresa Benezeder, Jack D. Crouch, Ira R. Kim, John T. O’Malley +18 more

Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-007675

N/A

0DataRank · unranked

27 citations

Yevgeniy R. Semenov, Allireza Alloo, Daniel Q. Bach, Allison Betof Warner, Amina Bougrine +36 more